Psilocybin to target persistent concussion symptoms in Australia's first clinical trial

Medical Xpress

Psilocybin to target persistent concussion symptoms in Australia's first clinical trial

Monash University researchers have launched Australia's first clinical trial to test whether the psychedelic drug psilocybin is an effective treatment for persistent post-concussion symptoms. ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

Psilocybin to target persistent concussion symptoms in Australia's first clinical trial

이 뉴스, 독자들은 어떻게 느꼈나요?

관련 뉴스

'science' 카테고리 뉴스

Utah's stricter 0.05 BAC limit significantly reduces drunk driving fatalities, analysis finds

Nebraska’s Wide, Rolling Domain

1940s-era drug helps uncover kidney pathway that may improve disease treatment

Medical Xpress의 다른 기사

New toolkit aims to improve menopause care for women from minority ethnic communities

Seeking health information does not automatically improve health behavior, says researcher

Youth-designed 'blue-green' spaces boost resilience and mental wellness for Appalachian adolescents